• Home
  • Contact Us
  • Sign Up for Email Alert
  • Careers
  • TSX-V:BCT: (%)
  • BCTXF: (%)
BriacellBriacell
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Search in posts
    Search in pages
  • About Us
    • About Briacell
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business Development
    • Privacy Policy
  • Technology
    • Bria-IMT™
    • Bria-OTS™
    • BriaDX™
    • PKCδ
    • Patents
    • Mechanism of Action of Bria-IMT™ and Bria-OTS™
    • Clinical Trials
    • Scientific Publications
  • In the News
    • Recent News
    • Recent Events
    • Media Coverage
  • Investor Relations
    • Corporate Profile
    • Presentations
    • Corporate Governance
    • News and Events
    • Filings
    • Shareholder Information
    • FAQ
    • Email Alerts
    • Contact Us
Recent Events

Bill Williams M.D. from BriaCell on CEO Money

Posted on December 5, 2017March 14, 2019 by admin001

Click here to read more

This entry was posted in Recent Events. Bookmark the permalink.
BriaCell Announces Advancement of its Small Molecule Program and Patent Allowance
Dr. Bill Williams Guest Appearance at “CEO Money” Radio Show
Recent News
  • BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th November 12, 2019
  • BriaCell Announces Voting Results of the Special Meeting of Shareholders October 24, 2019
  • BriaCell Announces Closing of Non-Brokered Private Placement of $568,444 October 15, 2019
  • BriaCell Therapeutics Corp. to File Amendment to Management Information Circular October 8, 2019
  • BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT™ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer October 7, 2019
Categories
  • Annual Reports
  • News and Events
    • Recent Events
    • Recent News
Archives
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015
  • June 2015
  • November 2014
  • April 2014

Corporate Office- Canada
Suite 300 - Bellevue Centre
235 -15th Street
West Vancouver, BC V7T 2X1
Tel: 604-921-1810
Fax: 604-921-1898

Corporate Office- US
820 Heinz Avenue
Berkeley, CA, 94710
Tel: 1-888-485-6340
Fax: 424-245-3719

About Us
  • About Briacell
  • Board of Directors
  • Management
  • Scientific Advisory Board
  • Business Development
  • Privacy Policy
Technology
  • Bria-IMT™
  • Bria-OTS™
  • BriaDX™
  • PKCδ
  • Patents
  • Mechanism of Action of Bria-IMT™ and Bria-OTS™
  • Clinical Trials
  • Scientific Publications
Investor Relations
  • Corporate Profile
  • Presentations
  • Corporate Governance
  • News and Events
  • Filings
  • Shareholder Information
  • FAQ
  • Email Alerts
  • Contact Us

Signup for our Email Alert!


Copyright 2019 © Briacell.| All rights reserved | XML Sitemap | HTML Sitemap
  • About Us
    • About Briacell
    • Board of Directors
    • Management
    • Scientific Advisory Board
    • Business Development
    • Privacy Policy
  • Technology
    • Bria-IMT™
    • Bria-OTS™
    • BriaDX™
    • PKCδ
    • Patents
    • Mechanism of Action of Bria-IMT™ and Bria-OTS™
    • Clinical Trials
    • Scientific Publications
  • In the News
    • Recent News
    • Recent Events
    • Media Coverage
  • Investor Relations
    • Corporate Profile
    • Presentations
    • Corporate Governance
    • News and Events
    • Filings
    • Shareholder Information
    • FAQ
    • Email Alerts
    • Contact Us
  • Home
  • Contact Us
  • Sign Up for Email Alert
  • Careers
  • TSX-V:BCT: (%)
  • BCTXF: (%)